Viewing Study NCT03185195


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-01-10 @ 8:33 AM
Study NCT ID: NCT03185195
Status: COMPLETED
Last Update Posted: 2017-06-14
First Post: 2017-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125
Sponsor: Aquinox Pharmaceuticals (Canada) Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module